AKT1 and glioblastoma: Furthermore, we identified key downstream factor of glioblastoma-derived EVs, PI3K-Akt pathway, as elevated proliferation and migration of mNPCs post EVs treatment could be reversed by PI3K inhibitor Wortamnnin.